AMCR — Amcor plc

Amcor Q3 2026 Earnings Call Summary

1. Key Financial Results and Metrics:

• Adjusted EPS: $0.96, up 6% year-over-year; YTD adjusted EPS of $2.79, an 11% increase.
• Revenue: $5.9 billion for Q3, driven by the Berry acquisition and disciplined cost management.
• EBITDA: $892 million; EBIT of $687 million, reflecting strong performance post-acquisition.
• Free Cash Flow: Outflow of $39 million for the quarter, with YTD outflow of $93 million; revised full-year guidance for free cash flow to $1.5 billion - $1.6 billion (down from $1.8 billion - $1.9 billion).
• Dividend: Quarterly dividend declared at $0.65 per share, slightly up from the previous year.

2. Strategic Updates and Business Highlights:

• Successful integration of legacy Amcor and Berry, achieving $77 million in synergies for Q3 and $170 million year-to-date; on track to exceed the $270 million synergy target for FY 2026.
• Portfolio optimization continues with six noncore business divestitures valued at approximately $500 million, with proceeds aimed at debt reduction.
• Focus categories (healthcare, beauty and wellness, proteins, liquids, foodservice, pet care) showed resilience, with core portfolio EBIT margins at 12.3%.
• Continued strong customer relationships and proactive supply chain management amid geopolitical tensions, particularly in the Middle East.

3. Forward Guidance and Outlook:

• Adjusted EPS guidance for FY 2026 is set at $3.98 to $4.03, implying approximately 12% growth year-over-year.
• Anticipated strong Q4 adjusted EPS growth of over 20%, reflecting the full impact of the Berry acquisition.
• Expectation of free cash flow recovery as supply chains normalize, with a commitment to deleveraging to a target leverage ratio of 2.5 to 3.0x by FY 2027.

4. Bad News, Challenges, or Points of Concern:

• Free Cash Flow Impact: Elevated inventory levels due to inflation and supply chain issues have led to a downward revision in free cash flow expectations.
• Volume Declines: Overall volumes down approximately 1.5% in Q3, with specific weakness in healthcare and nutrition categories attributed to external factors like winter storms and consumer spending pressures.
• Geopolitical Risks: While the company does not expect significant impact from the Middle East conflict, ongoing inflationary pressures and supply chain volatility remain concerns.
• Leverage Ratio: Expected year-end leverage of 3.4 to 3.5x, higher than previous guidance, which may impact financial flexibility.

5. Notable Q&A Insights:

• Management emphasized that the Middle East conflict has minimal direct exposure for Amcor, with less than 5% of resin sourced from the region.
• Discussions with customers regarding pricing adjustments are collaborative, focusing on maintaining supply continuity amid rising costs.
• There is cautious optimism about consumer demand, with expectations of low single-digit declines in the second half of the calendar year.
• The company remains committed to its synergy targets and is confident in its ability to navigate procurement challenges while maintaining strong customer relationships.

Overall, Amcor's Q3 2026 results reflect solid operational execution and strategic progress, despite facing external challenges and a need for careful management of cash flow and leverage.